[hlHome]

0

Back to Resectable Non-Small Cell Lung Cancers: The Role of Biomarker Testing and Evaluation of Pathological Response Following Neoadjuvant Treatment
Resectable Non-Small Cell Lung Cancers: The Role of Biomarker Testing and Evaluation of Pathological Response Following Neoadjuvant Treatment

Resectable Non-Small Cell Lung Cancers: The Role of Biomarker Testing and Evaluation of Pathological Response Following Neoadjuvant Treatment

 

This activity is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving the diagnosis, biomarker testing, and treatment of patients with resectable non-small cell lung cancer (NSCLC).

  • List Price: Free
Item Details:

Activity Overview

This activity is designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving the diagnosis, biomarker testing, and treatment of patients with resectable non-small cell lung cancer.

Course topics include:

•

Back to Resectable Non-Small Cell Lung Cancers: The Role of Biomarker Testing and Evaluation of Pathological Response Following Neoadjuvant Treatment
View More View Less

Bought This Bought That ...